标题
Toll-like receptor agonists: a patent review (2011 – 2013)
作者
关键词
-
出版物
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 24, Issue 4, Pages 453-470
出版商
Informa Healthcare
发表日期
2014-01-24
DOI
10.1517/13543776.2014.880691
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Self-Adjuvanting Polymer–Peptide Conjugates As Therapeutic Vaccine Candidates against Cervical Cancer
- (2013) Tzu-Yu Liu et al. BIOMACROMOLECULES
- Phase I study of tremelimumab (CP-675 206) plus PF-3512676 (CPG 7909) in patients with melanoma or advanced solid tumours
- (2013) M Millward et al. BRITISH JOURNAL OF CANCER
- Targeting Toll-like receptors with small molecule agents
- (2013) Xiaohui Wang et al. CHEMICAL SOCIETY REVIEWS
- Modern Subunit Vaccines: Development, Components, and Research Opportunities
- (2013) Peter Michael Moyle et al. ChemMedChem
- The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma
- (2013) Kai-Michael Beeh et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands
- (2013) H. Tanji et al. SCIENCE
- Prolonged subcutaneous administration of 852A, a novel systemic toll-like receptor 7 agonist, to activate innate immune responses in patients with advanced hematologic malignancies
- (2012) Brenda J. Weigel et al. AMERICAN JOURNAL OF HEMATOLOGY
- Structural basis of innate immune recognition of viral RNA
- (2012) Ian C. Berke et al. CELLULAR MICROBIOLOGY
- Topical TLR7 Agonist Imiquimod Can Induce Immune-Mediated Rejection of Skin Metastases in Patients with Breast Cancer
- (2012) S. Adams et al. CLINICAL CANCER RESEARCH
- New developments in Toll-like receptor targeted therapeutics
- (2012) Dympna J Connolly et al. CURRENT OPINION IN PHARMACOLOGY
- Advances in Peptide-based Human Papillomavirus Therapeutic Vaccines
- (2012) Tzu-Yu Liu et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Topical Treatment with the Toll-like Receptor Agonist DIMS0150 Has Potential for Lasting Relief of Symptoms in Patients with Chronic Active Ulcerative Colitis by Restoring Glucocorticoid Sensitivity
- (2012) Eugen Musch et al. INFLAMMATORY BOWEL DISEASES
- Safety and Immunogenicity of Vaccination With MART-1 (26–35, 27L), gp100 (209–217, 210M), and Tyrosinase (368–376, 370D) In Adjuvant With PF-3512676 and GM-CSF In Metastatic Melanoma
- (2012) Ahmad A. Tarhini et al. JOURNAL OF IMMUNOTHERAPY
- Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand
- (2012) Abu-Baker M. Abdel-Aal et al. JOURNAL OF MEDICINAL CHEMISTRY
- Results of a Phase 1 Dose Escalation Study of Intravesical TMX-101 in Patients with Nonmuscle Invasive Bladder Cancer
- (2012) Johannes Falke et al. JOURNAL OF UROLOGY
- Liposome-based delivery system for vaccine candidates: constructing an effective formulation
- (2012) Ashwini Kumar Giddam et al. Nanomedicine
- Genetic variation in Toll-like receptors and disease susceptibility
- (2012) Mihai G Netea et al. NATURE IMMUNOLOGY
- Synthetic Toll Like Receptor-4 (TLR-4) Agonist Peptides as a Novel Class of Adjuvants
- (2012) Arulkumaran Shanmugam et al. PLoS One
- A Double-Blind, Placebo-Controlled, Randomized, Clinical Trial of the TLR-3 Agonist Rintatolimod in Severe Cases of Chronic Fatigue Syndrome
- (2012) David R. Strayer et al. PLoS One
- Peptide-Based Subunit Vaccine against Hookworm Infection
- (2012) Mariusz Skwarczynski et al. PLoS One
- Structural basis of species-specific endotoxin sensing by innate immune receptor TLR4/MD-2
- (2012) U. Ohto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Repeated intranasal TLR7 stimulation reduces allergen responsiveness in allergic rhinitis
- (2012) Lennart Greiff et al. RESPIRATORY RESEARCH
- Demonstration of safety and enhanced seroprotection against hepatitis B with investigational HBsAg-1018 ISS vaccine compared to a licensed hepatitis B vaccine
- (2012) Benjamin P. Sablan et al. VACCINE
- TLR9-adjuvanted pneumococcal conjugate vaccine induces antibody-independent memory responses in HIV-infected adults
- (2012) Rasmus Offersen et al. Human Vaccines & Immunotherapeutics
- Toll-Like Receptor 8 Ligands Activate a Vitamin D Mediated Autophagic Response that Inhibits Human Immunodeficiency Virus Type 1
- (2012) Grant R. Campbell et al. PLoS Pathogens
- Peptide-Based Subunit Nanovaccines
- (2012) Mariusz Skwarczynski et al. Current Drug Delivery
- Trial Watch
- (2012) Lorenzo Galluzzi et al. OncoImmunology
- Randomised clinical trial: anti-viral activity of ANA773, an oral inducer of endogenous interferons acting via TLR7, in chronic HCV
- (2011) J. F. Bergmann et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- A phase III randomized study of gemcitabine and cisplatin with or without PF-3512676 (TLR9 agonist) as first-line treatment of advanced non-small-cell lung cancer
- (2011) C. Manegold et al. ANNALS OF ONCOLOGY
- Simple synthetic toll-like receptor 2 ligands
- (2011) Abu-Baker M. Abdel-Aal et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Assessment of clinical efficacy of CYT003-QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study
- (2011) L. Klimek et al. CLINICAL AND EXPERIMENTAL ALLERGY
- Phase I Study Utilizing a Novel Antigen-Presenting Cell-Targeted Vaccine with Toll-like Receptor Stimulation to Induce Immunity to Self-antigens in Cancer Patients
- (2011) M. A. Morse et al. CLINICAL CANCER RESEARCH
- The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)
- (2011) M D Fidock et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Toll-like receptors
- (2011) Eva Marie Y. Moresco et al. CURRENT BIOLOGY
- Toll-like receptor modulators: a patent review (2006 – 2010)
- (2011) Shaherin Basith et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Toll-like Receptors and Their Crosstalk with Other Innate Receptors in Infection and Immunity
- (2011) Taro Kawai et al. IMMUNITY
- Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry
- (2011) Annette Plüddemann et al. IMMUNOLOGICAL REVIEWS
- Randomized Phase III Trial of Paclitaxel/Carboplatin With or Without PF-3512676 (Toll-Like Receptor 9 Agonist) As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer
- (2011) Vera Hirsh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia
- (2011) Clive S. Zent et al. LEUKEMIA & LYMPHOMA
- Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers
- (2011) Dianna Rynkiewicz et al. VACCINE
- Structural requirement for the agonist activity of the TLR2 ligand Pam2Cys
- (2010) Weiguang Zeng et al. AMINO ACIDS
- Polyacrylate Dendrimer Nanoparticles: A Self-Adjuvanting Vaccine Delivery System
- (2010) Mariusz Skwarczynski et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- Sublingual Allergen-Specific Immunotherapy Adjuvanted with Monophosphoryl Lipid A: A Phase I/IIa Study
- (2010) Oliver Pfaar et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Cutting Edge: Type I IFN Reverses Human Th2 Commitment and Stability by Suppressing GATA3
- (2010) J. P. Huber et al. JOURNAL OF IMMUNOLOGY
- Memory and Effector CD8 T-cell Responses After Nanoparticle Vaccination of Melanoma Patients
- (2010) Daniel E. Speiser et al. JOURNAL OF IMMUNOTHERAPY
- Additive melanoma suppression with intralesional phospholipid-conjugated TLR7 agonists and systemic IL-2
- (2010) Tomoko Hayashi et al. MELANOMA RESEARCH
- Self-adjuvanting polyacrylic nanoparticulate delivery system for group A streptococcus (GAS) vaccine
- (2010) Mehfuz Zaman et al. Nanomedicine-Nanotechnology Biology and Medicine
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Targeting Toll-like receptors: emerging therapeutics?
- (2010) Elizabeth J. Hennessy et al. NATURE REVIEWS DRUG DISCOVERY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- Structure–activity relationship of lipopeptide Group A streptococcus (GAS) vaccine candidates on toll-like receptor 2
- (2010) Mehfuz Zaman et al. VACCINE
- Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists
- (2009) Jörg Vollmer et al. ADVANCED DRUG DELIVERY REVIEWS
- Drugs targeting toll-like receptors
- (2009) Jayalakshmi Krishnan et al. ARCHIVES OF PHARMACAL RESEARCH
- Lipid Core Peptide System for Gene, Drug, and Vaccine Delivery
- (2009) Wei Zhong et al. AUSTRALIAN JOURNAL OF CHEMISTRY
- American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer
- (2009) Christopher G. Azzoli et al. JOURNAL OF CLINICAL ONCOLOGY
- The Effects of Cytokines on Suppression of Lymphocyte Proliferation by Dexamethasone
- (2009) T. J. Creed et al. JOURNAL OF IMMUNOLOGY
- The structural basis of lipopolysaccharide recognition by the TLR4–MD-2 complex
- (2009) Beom Seok Park et al. NATURE
- Toll-like receptor 2 dependent immunogenicity of glycoconjugate vaccines containing chemically derived zwitterionic polysaccharides
- (2009) S. Gallorini et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Innate immune sensing and activation of cell surface Toll-like receptors
- (2009) Richard I. Tapping SEMINARS IN IMMUNOLOGY
- In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli
- (2009) Shuang Liang et al. VACCINE
- Self-Adjuvanting Lipopeptide Vaccines
- (2008) Peter Moyle et al. CURRENT MEDICINAL CHEMISTRY
- Functional diversification of the toll-like receptor gene family
- (2008) Austin L. Hughes et al. IMMUNOGENETICS
- TLR7 Agonist 852A Inhibition of Tumor Cell Proliferation Is Dependent on Plasmacytoid Dendritic Cells and Type I IFN
- (2008) Jon R. Inglefield et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Toll-like receptor 9 (TLR9) agonists in the treatment of cancer
- (2008) A M Krieg ONCOGENE
- Toll-like receptors and immune regulation: implications for cancer therapy
- (2008) R-F Wang et al. ONCOGENE
- TLR7 and TLR8 as targets in cancer therapy
- (2008) M P Schön et al. ONCOGENE
- Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA
- (2008) L. Liu et al. SCIENCE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started